Nuvectis Pharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$21.00

-0.08 (-0.38%)

As of Nov 14, 2:17 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +30.5% upside

Low Target $23.46

Average Target $27.40

High Target $40.51

Current Price $21.00

Current
$21.00

Target
$27.40

$23.46 $27.40 avg $40.51

Scenario Analysis

Bear Case

$23.46

11.7%

Low target

Base Case

$27.40

+30.5%

Avg target

Bull Case

$40.51

+92.9%

High target

Risk/Reward

7.9x

Highly favorable

Price in Context

52-Week High

$29.28

-28.3% from high

52-Week Low

$5.77

+264.0% from low

Target vs 52W High

$27.40

-6.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%